THE MHE RESEARCH FOUNDATION

What THE MHE RESEARCH FOUNDATION does

The MHE Research Foundation is a small, Brooklyn, New York-based non-profit organization dedicated to multiple hereditary exostoses (MHE), a rare genetic musculoskeletal disorder characterized by the growth of multiple benign bone tumors. According to its stated mission, the Foundation provides education, patient support, research collaboration, and maintains disease registries for the MHE patient and caregiver community.

Its core offerings are programmatic rather than commercial: educational resources for patients and families, support services for those affected by MHE, facilitation of research collaboration among clinicians and scientists studying the condition, and operation of patient registries that aggregate clinical and demographic data. The organization's website domain (mheresearchfoundation.org) confirms a research-and-advocacy orientation, though the website was inaccessible at the time of extraction (displayed only a verification/loading screen), limiting further product-level detail.

The Foundation is structured as a non-profit with 1-10 employees and is privately held, with no commercial revenue model evident in the available data. Its go-to-market is mission-driven: reaching MHE patients, families, clinicians, and researchers through advocacy channels rather than commercial sales. No funding rounds, grants, donor disclosures, sponsorships, or partnership agreements were present in the input data, indicating either low public financial disclosure or a data gap. No leadership team, board, partnerships, geographic footprint details, or strategic milestones were extractable.

Name

THE MHE RESEARCH FOUNDATION

Website

https://mheresearchfoundation.org

Company type

Private

Headcount range

1–10 employees

Short description

The MHE Research Foundation is a small Brooklyn-based non-profit that provides education, patient support, research collaboration, and disease registries for patients and families affected by multiple hereditary exostoses (MHE), a rare genetic bone disorder.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Advocacy and Research

NAICS

Other Individual and Family Services (624190)

SIC

Services-Social Services (8300)

akta.pro industry

PRIMARYBPAGACAM

Rare Disease & Special Needs Support Organizations

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

SECONDARYBPAGACAA

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

Keywords

• Rare disease foundation
• Patient support services
• Medical research collaboration
• Patient registry programs
• Patient education resources

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

The MHE Research Foundation provides education, patient and family support, research collaboration, and patient registries focused on Multiple Hereditary Exostoses (MHE). Its activities are organized around a single rare bone condition, channeling resources to affected patients, their families, clinicians, and researchers studying the disease.

Differentiator

Problem solved

Functional benefit

Products and services

• MHE Patient Education Programs

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• EveryLife Foundation for Rare Diseases: Advocacy non-profit focused on policy and legislative action for the broader rare disease community. Comparable mission alignment around rare-disease patient support and research enablement, though oriented toward policy rather than a single disease.
• Genetic Alliance: Non-profit federation of disease-specific advocacy groups and genetic condition communities. Directly comparable as a parent-like platform for hereditary/genetic disease foundations, offering shared infrastructure for registries and research engagement.
• National Organization for Rare Disorders (NORD): Largest US umbrella organization for rare diseases, providing patient advocacy, education, and research support across hundreds of conditions. Comparable as a rare-disease support platform that the MHE Research Foundation either complements or competes against for awareness and funding.
• National Bone Health Alliance: Multi-stakeholder coalition focused broadly on bone health, including rare bone disorders. Comparable as an educational and research-convener platform relevant to hereditary bone conditions like MHE.

Direct peers

• Osteogenesis Imperfecta Foundation: Disease-specific foundation serving people with OI, a rare genetic bone disorder. Highly comparable as a small specialized non-profit addressing a rare hereditary bone condition through support, education, and research collaboration.
• The MAGIC Foundation: Non-profit supporting children with various growth disorders and rare conditions, providing education, family support, and research connections. Comparable small rare-disease foundation operating model centered on patient/community support.
• Cure SMA (Spinal Muscular Atrophy): Leading disease-specific non-profit for SMA, combining patient support, research funding, and registry development. Comparable rare-disease foundation model that has successfully partnered with pharmaceutical developers on therapy approvals.
• Children's Tumor Foundation: Disease-specific non-profit focused on neurofibromatosis, combining patient support, research funding, and clinical collaboration. Closely comparable operating model to a small rare-disease foundation delivering education, support, and research partnerships.
• Aplastic Anemia & MDS International Foundation: Non-profit supporting patients with rare bone marrow failure diseases through education, peer support, and research funding. Comparable small rare-disease foundation providing integrated patient and research services.

Emerging players

• Orphanet: International reference portal for rare diseases and orphan drugs, providing disease descriptions, registries, and research resources. Comparable as a knowledge infrastructure for rare-disease communities, particularly relevant to MHE's registry and education mission.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/the-mhe-research-foundation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about THE MHE RESEARCH FOUNDATION